August, 25 2020, 12:00am EDT
Another Broken Promise: Trump's Empty Drug Pricing Bluff Called By Pharma As August 24th Deadline Comes and Goes With No Action
Today, Accountable Pharma released the following statement after President Trump's August 24th deadline for the drug companies to come up with "something that will substantially reduce drug prices" or face his "international pricing index" executive order came and went with no word from the White House on any action.
WASHINGTON
Today, Accountable Pharma released the following statement after President Trump's August 24th deadline for the drug companies to come up with "something that will substantially reduce drug prices" or face his "international pricing index" executive order came and went with no word from the White House on any action.
"Once again President Trump talked a big game about cutting drug prices and followed it up with absolutely nothing but another broken promise to patients and families," said Eli Zupnick, spokesman for Accountable Pharma. "For a president to issue a threat like this and then allow the drug industry to walk all over him would be laughable if it wasn't so deadly serious for the patients and families who have seen their drug prices go up year after year while drug company profits went through the roof."
"When President Trump talks about his plans to cut drug prices sometime in the future he should be asked what he's done to deliver the '50, 60, even 70%' price reductions he has been guaranteeing for years."
Trump's big promise in July: "...we're going to hold that [executive order] until August 24th, hoping that the pharmaceutical companies will come up with something that will substantially reduce drug prices. And the clock starts right now. So it's August 24th at 12:00, after which the order on favored nations will go into effect."
Trump doubled down last week: "Drug prices will be coming down 50, 60, even 70%"
But when the deadline hit: "...federal law required signed executive orders to be published in the Federal Register. No 'favored nation' order has appeared, so the missing order either violates the law or is incomplete."
The executive orders had been widely panned as unlikely to have any impact this year even if they were actually implemented. Following his announced executive orders, the pharmaceutical industry cancelled a White House meeting with President Trump while assuring their shareholders that they don't expect Trump's executive orders to have any impact during his term.
Trump Claimed He Was Enacting "Favored Nations" Reforms To Lower Drug Prices At Least Three Times In Last Three Years--Promising "Transformative" And "Revolutionary" Change Each Time
- July 24, 2020: "I'm taking a bold and historic, very dramatic action to reduce the price of prescription drugs for American patients and American seniors. . . . Under this transformative order, Medicare will be required to purchase drugs at the same price as other countries pay. . . . But we have--we get now the lowest price anywhere in the world. And no more will we have to suffer by saying, "Gee, why is it so much cheaper for the exact same drug in some other country?"
- July 5, 2019: "We're going to be announcing something very shortly ... We're working on a favored nations clause, where we pay whatever lowest nation's price is. Why should other nations, like Canada--but why should other nations pay much less than us? They've taken advantage of the system for a long time--pharma. So we're working on, right now, a favored nations clause, so that whatever the lowest nation is, anywhere in the world--or company--but the lowest nation or company. Then what happens is we will pay that amount, and that's being worked on right now. We're going to do it in the form of an executive order."
- October 25, 2018: "Not anymore. Under our new plan, the Department of Health and Human Services would allow Medicare to determine the price it pays for certain drugs based on the cheaper prices paid by other nations. Some people call it "favored nations clauses." . . . At long last, the drug companies and foreign countries will be held accountable for how they rigged the system against American consumers. This is a revolutionary change. Nobody has had the courage to do it, or they just didn't want to do it."
President Trump Has Been Making Promises On Drug Prices For Years . . .
- February 4, 2020: "I was pleased to announce last year that, for the first time in 51 years, the cost of prescription drugs actually went down."
- July 5, 2019: "We're going to be announcing something very shortly ... We're working on a favored nations clause, where we pay whatever lowest nation's price is. Why should other nations, like Canada -- but why should other nations pay much less than us? They've taken advantage of the system for a long time--pharma. So we're working on, right now, a favored nations clause, so that whatever the lowest nation is, anywhere in the world--or company--but the lowest nation or company. Then what happens is we will pay that amount, and that's being worked on right now. We're going to do it in the form of an executive order."
- April 24, 2019: "Many drug companies are giving European countries a better deal than they give their own country. And that has to stop. We've already informed them that's stopping."
- February 6, 2019: "It's unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place. This is wrong, this is unfair, and together we will stop it--and we'll stop it fast."
- January 23, 2019: "I just had a meeting on drug pricing and various other things. And prescription drugs, for the first time in history--the history of our country--have gone down in 2018."
- October 25, 2018: "This really is an important day for me. I've been talking about drug price reductions for a long time. And now we're doing things that nobody was, let's say--because I'm speaking on behalf of all of us--bold enough to do. And they're going to have a tremendous impact. . . . We're fighting for lower drug prices, which will now be automatic. It will be automatic and very substantial."
- March 19, 2018: "You'll be seeing drug prices falling very substantially in the not-too-distant future, and it's going to be beautiful."
- January 30, 2018: "One of my greatest priorities is to reduce the price of prescription drugs... I have directed my administration to make fixing the injustice of high drug prices one of our top priorities for the year. And prices will come down substantially--watch."
- February 28, 2017: "[I will] work to bring down the artificially high price of drugs, and bring them down immediately."
And Latest Executive Order Proclamations Were Met With Skepticism
- Salon: "Pharma CEOs privately scoff at Trump's drug pricing orders: "Not expecting any impact."
- Washington Post: "Trump signs executive orders aimed at lowering drug prices in largely symbolic move. The orders are unlikely to take effect anytime soon, if they do so at all."
- STAT News: "...it's unclear whether the effort to make progress on drug pricing will pay off, given that Trump can't immediately enact any of the policies. Rather, the orders direct his administration to begin the normal, notoriously slow regulatory processes needed to reform the existing system. The administration will have to speed through that process to formalize any of the policies before November."
- Politico: "'The drug EOs are a way to give the appearance of movement on Trump's pricing agenda without actually doing anything,' wrote Capital Alpha Partners' Rob Smith in a note, adding that the original favored nations rule has languished with budget officials for more than a year. 'A more impactful step would be to issue this actual proposed rule and begin the process of finalizing it rather than holding what amounts to a glorified press conference.'"
- NYT: "Mr. Trump's executive orders may have more symbolic meaning than any kind of immediate practical consequence."
- NPR: "The prescription drug bill that stalled after passing in the House in December, called HR3, would have had a much larger impact, says Stacie Dusetzina, a health policy professor at Vanderbilt University. "The bottom line is that these orders will not make a meaningful difference for patients when it comes to what they pay out-of-pocket for their medications," Dusetzina writes in an email to NPR."
MEANWHILE: Drug Prices Have Continued To Soar...
- Politico: "Drug prices steadily rise amid pandemic, data shows."
- Politifact: "Donald Trump wrong again about prescription drug prices."
- HealthDay: "U.S. Drug Prices Have Risen Three Times Faster Than Inflation."
- CBS News: "2020 is three days old and drug prices are already jumping."
- The Hill: "Survey: About 1 in 10 US adults rationing medicine in effort to lower costs."
... As Drug Companies Rake In Record Profits...
- West Health Policy Center: "New Analysis Finds Large Drugmakers Could Lose $1 Trillion in Sales and Still Be the Most Profitable Industry."
- Axios: "Health care CEO pay outstrips infectious disease research."
- Newsweek: "Big Pharma Companies Earn More Profits Than Most Other Industries, Study Suggests."
- FiercePharma: "How the 8 biggest U.S. pharmas enriched their shareholders in 2019."
- Axios: "Big Pharma is on a stock buyback spree."
- Axios: "4 pharma companies saved $7 billion from GOP tax law."
And Industry Executives Fill The Top Levels Of The Administration
- NYT: "Trump's Vaccine Chief Has Vast Ties to Drug Industry, Posing Possible Conflicts."
- Reuters: "Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief."
- Politico: "Trump picks ex-pharma executive Azar to lead HHS."
- Politico: "Former drug industry lobbyist helps steer Trump drug plan."
- Politico: "Trump's HHS secretary nominee boosted drug prices while at Eli Lilly."
Accountable.US is a nonpartisan watchdog that exposes corruption in public life and holds government officials and corporate special interests accountable by bringing their influence and misconduct to light. In doing so, we make way for policies that advance the interests of all Americans, not just the rich and powerful.
LATEST NEWS
Amid Spying Fight, House Passes Fourth Amendment Is Not For Sale Act
"As FANFSA and the 702 reauthorization move to the Senate, lawmakers in that chamber need to take a stand for the rights of people in the United States," said one advocate.
Apr 17, 2024
While applauding the U.S. House of Representatives' bipartisan passage of a bill to ensure that "law enforcement and intelligence agencies can't do an end-run around the Constitution by buying information from data brokers" on Wednesday, privacy advocates highlighted that Congress is trying to extend and expand a long-abused government spying program.
The House voted 219-199 for Fourth Amendment Is Not For Sale Act (FANFSA), which won support from 96 Democrats and 123 Republicans, including the lead sponsor, Rep. Warren Davidson (R-Ohio). Named for the constitutional amendment that protects against unreasonable searches and seizures, H.R. 4639 would close what campaigners call the data broker loophole.
"The privacy violations that flow from law enforcement entities circumventing the Fourth Amendment undermine civil liberties, free expression, and our ability to control what happens to our data," said Free Press Action policy counsel Jenna Ruddock. "These impacts affect everyone who uses digital platforms that extract our personal information any time we open a browser or visit social media and other websites—even when we go to events like demonstrations and other places with our phones revealing our locations."
"We're grateful that the House passed these vital and popular protections," she added. "The bill would prevent flagrant abuses of our privacy by government authorities in league with unscrupulous third-party data brokers. Making this legislation into law with Senate passage too would be a decisive and long-overdue action against government misuse of this clandestine business sector that traffics in our personal data for profit."
Wednesday's vote followed the House sending the Reforming Intelligence and Securing America Act to the Senate. H.R. 7888 would reauthorize Section 702 of the Foreign Intelligence Surveillance Act (FISA), which allows for warrantless spying on noncitizens abroad but also sweeps up Americans' data.
The House notably included an amendment forcing a wide range of individuals and businesses to cooperate with government spying operations but rejected an amendment that would have added a warrant requirement to the bill, which the Senate could vote on as soon as Thursday.
Noting those decisions on the FISA reauthorization legislation, Ruddock stressed that "today's vote is a victory but follows a recent loss and ongoing threat as that Section 702 bill moves to the Senate this week too."
"As FANFSA and the 702 reauthorization move to the Senate, lawmakers in that chamber need to take a stand for the rights of people in the United States," she argued. "That means passing FANFSA and reforming Section 702 authority—and prioritizing everyone's First and Fourth Amendment rights."
Jeramie Scott, senior counsel and director of the Electronic Privacy Information Center's Project on Surveillance Oversight, also praised the House's FANFSA passage on Wednesday.
"The passage of the Fourth Amendment Is Not For Sale underscores the extent to which reining in abusive warrantless surveillance is a bipartisan issue," Scott said. "We urge the Senate to take up this measure and close the data broker loophole."
Kia Hamadanchy, senior policy counsel at ACLU, similarly said Wednesday that "the bipartisan passage of this bill is a flashing warning sign to the government that if it wants our data, it must get a warrant."
Hamadanchy added that "we hope this vote puts a fire under the Senate to protect their constituents and rein in the government's warrantless surveillance of Americans, once and for all."
Sen. Ron Wyden (D-Ore.), a critic of the pending 702 bill and FANFSA's lead sponsor in the upper chamber, called the the House's Wednesday vote "a huge win for privacy" and said that "now it's time for the Senate to follow suit."
Keep ReadingShow Less
Leaked Cables Show Biden Pressuring Nations to Oppose Palestine's UN Membership
"This is the evidence that President Biden's talk about a two-state solution is nothing but idle talk," said one former Lebanese diplomat.
Apr 17, 2024
As the United Nations Security Council prepares to vote Thursday on Palestine's bid to become a full U.N. member, the Biden administration—which claims to support Palestinian statehood—is lobbying UNSC nations in an effort to wrangle enough "no" votes so that the United States can avoid resorting to a veto.
Leaked cables obtained by The Intercept show U.S. pressure on Security Council members including Malta—which currently presides over the body—and Ecuador.
While claiming that President Joe Biden backs "Palestinian aspirations for statehood," one of the cables asserts that "it remains the U.S. view that the most expeditious path toward a political horizon for the Palestinian people is in the context of a normalization agreement between Israel and its neighbors."
"We therefore urge you not to support any potential Security Council resolution recommending the admission of 'Palestine' as a U.N. member state, should such a resolution be presented to the Security Council for a decision in the coming days and weeks," the document advises.
The U.S. argument essentially is that the U.N. should not create an independent Palestinian state by fiat—even though that's precisely how the world body voted in 1947 to establish the modern state of Israel.
The renewed push for Palestine's U.N. membership comes as Israel wages a genocidal war on the Gaza Strip. The Palestinian Authority, which hasn't controlled Gaza for nearly two decades, rejected the Biden administration's requests to hold off on seeking full membership.
"We wanted the U.S. to provide a substantive alternative to U.N. recognition. They didn't," one unnamed Palestinian official toldAxios on Wednesday. "We believe full membership in the U.N. for Palestine is way overdue. We have waited more than 12 years since our initial request."
As The Intercept's Ken Klippenstein and Daniel Boguslaw noted:
Since 2011, the U.N. Security Council has rejected the Palestinian Authority's request for full member status. On April 2, the Palestinian Observer Mission to the U.N. requested that the council once again take up consideration of its membership application. According to the first State Department cable, U.N. meetings since the beginning of April suggest that Algeria, China, Guyana, Mozambique, Russia, Slovenia, Sierra Leone, and Malta support granting Palestine full membership to the U.N. It also says that France, Japan, and Korea are undecided, while the United Kingdom will likely abstain from a vote.
Along with the United States, China, France, Russia, and the United Kingdom are permanent members of the UNSC, so they also have veto power.
Ahead of Thursday's planned vote, Spain has been doing its own lobbying in Europe to build greater support for Palestinian statehood. At a joint Tuesday press conference with Spanish Prime Minister Pedro Sánchez, Slovenian Prime Minister Robert Golob said the question is "when, not if, but when is the best moment to recognize Palestine."
Belgium—which is seeking economic sanctions against Israel in response to its genocidal war on Gaza—is expected to join Spain's push for Palestinian statehood after the country's European Union presidency expires in June.
Currently, 139 of the U.N.'s 193 member states recognize Palestine as an independent state.
Israeli Prime Minister Benjamin Netanyahu—who has also claimed to support a so-called "two-state solution"—has alternately boasted about thwarting Palestinian statehood.
Critics pointed to the leaked cables as more proof of U.S. duplicity and double standards on the Israel-Palestine issue.
"This is the evidence that President Biden's talk about a two-state solution is nothing but idle talk," Massoud Maalouf, a former Lebanese ambassador to Canada, Chile, and Poland, said on social media.
Keep ReadingShow Less
Database Exposes 'Illicit Network Undermining Democracy Around the World'
Yanis Varoufakis hailed the effort as "a treasure chest of well-researched reports on how the reactionaries of the world unite."
Apr 17, 2024
"Coups. Assassinations. Riots. Detentions. Disinformation. We know the tactics that have been deployed to undermine our democracies. But who is behind them?"
Progressive International (PI) asks and answers this and other questions with an extensive new database published Wednesday that connects the dots in what the leftist group calls the "Reactionary International"—a loose global network of right-wing leaders and organizations working to subvert democratic institutions.
PI calls it an "illicit network undermining democracy around the world."
"Today is a mask-off moment for the Reactionary International and the parties, politicians, judges, journalists, foundations, think tanks, tech platforms, NGOs, activists, financiers, and entrepreneurs that comprise it," PI said.
"After a year of preparation, we finally open the doors to our new research consortium, exposing the global network of reactionary forces that corrode our democracies, destroy our planet, and drive us closer to world war," the group added.
"The twin insurrections at the U.S. Capitol in 2021 and BrasĂlia's Three Powers Plaza in 2023 left no doubt about the international coordination of reactionary forces," PI argued. "Yet far too little is known about the entities of this network, their sources of financing, and their institutional allies operating inside our political systems."
Ultimately, PI aims to "support democratic systems to become more resilient to their insidious tactics."
From leaders like Hungarian Prime Minister Viktor Orbán, Indian Prime Minister Narendra Modi, and former U.S. President Donald Trump—the presumptive 2024 Republican presidential nominee—to evangelical Christian groups influencing laws in African countries criminalizing LGBTQ+ people and tech companies empowering ubiquitous state surveillance, Reactionary International is a who's-who of the world's right-wing forces.
A cursory search of the database's contents shows users can:
- Learn about Israel's NSO, Rayzone, and Team Jorge, and how a team of Tel Aviv tech entrepreneurs fuel unrest in Latin America;
- Meet the Grey Wolves, Turkey's roving death squad with links to President Recep Tayyip ErdoÄźan and the ethno-nationalists in his governing coalition; and
- Explore the global network of the Falun Gong, its Trump-connected media outlet The Epoch Times, and its traveling dance troupe known as Shen Yun.
Yanis Varoufakis, a PI member and secretary-general of the left-wing Democracy in Europe Movement 2025, called the database "a treasure chest of well-researched reports on how the reactionaries of the world unite."
PI invites the public to contribute to the database.
"Together, we will not only name, shame, and expose the forces of the far right—but also dismantle their network of complicity," the group said.
Keep ReadingShow Less
Most Popular